Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
The journal of nutrition, health & aging
Metadata
Title
Merckel cell carcinoma: The impact of multidisciplinary management
Authors
S. Miranda
X. Gbaguidi
P. Carvalho
P. Chassagne
Publication date
01-02-2013
Publisher
Springer-Verlag
Published in
The journal of nutrition, health & aging / Issue 2/2013
Print ISSN: 1279-7707
Electronic ISSN: 1760-4788
DOI
https://doi.org/10.1007/s12603-012-0375-7

Other articles of this Issue 2/2013

The journal of nutrition, health & aging 2/2013 Go to the issue

OriginalPaper

Percutaneous endoscopic gastrostomy (PEG) tube feeding of nursing home residents is not associated with improved body composition parameters

OriginalPaper

A survey of physicians who care for older persons in Southwest China

OriginalPaper

Under-reporting of energy intake in elderly Australian women is associated with a higher body mass index

OriginalPaper

Characteristics of patients who stop falling after a risk-based multidisciplinary intervention initiated in a geriatric day hospital

OriginalPaper

Challenges in managing the diet of older adults with early-stage Alzheimer dementia: A caregiver perspective

OriginalPaper

Multidisciplinary team meetings (MDTM) in detection of Alzheimer’s disease: Data from the idem study

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits